Vetter has moved into new headquarters located in Ravensburg, Germany, and plans to continue its long-term investment for corporate development.
Global contract development and manufacturing organization (CDMO), Vetter, has announced its move into new headquarters located in Ravensburg, Germany, and plans to continue long-term investment for corporate development.
According to an Oct. 21, 2020 press release, the new Ravensburg Vetter Kammerbruehl has been opened in response to the company’s growing headcount and changing circumstances. The new headquarters is designed for approximately 1000 employees, while the former headquarters has been modified to be used as a training center and house the Vetter Academy.
Additionally, Vetter has invested in other sites, such as a new combination building for manual visual inspection and secondary packaging at its Ravensburg Vetter Sued site, and a cleanroom for prefilled syringe manufacturing at the Schuetzenstrasse site, which is expected to be operational in 2021.
“We are relying on sustainable and future-oriented activities with the focus on our customers and their patients,” said Peter Soelkner, managing director, Vetter, in the press release.“Part of our 360-degree approach includes investments in the expansion of our development capacities. We have observed a steady increase in demand from our customers as well as ever-more complex requirements for modern compounds.”
Further expansion is also planned by the company in the area of quality control. After Vetter’s implementation of a machine for automated visual inspection, the company has revealed plans to purchase three additional units for the Center for Visual Inspection and Logistics.
“We want to provide sufficient resources for the important step of final quality control and, at the same time, create greater flexibility,” added Thomas Otto, managing director, Vetter, in the press release. “These actions will even better enable us to offer our customers either manual or automatic visual inspection depending on individual batch sizes and special characteristics of their products.”
Source: Vetter
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.